Center for Drug Safety & Effectiveness
Drawing on the combined expertise of the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins School of Medicine, the Center for Drug Safety and Effectiveness serves as a nexus for individuals at Johns Hopkins who are involved in research, education, clinical programs and public service to improve prescription drug use and pharmaceutical policy in the United States and around the world. The unparalleled knowledge base of the Center’s core faculty reflects a diversity of fields, ranging from pharmacovigilance to regulatory policy.
News
- Drugmakers Push Profitable, but Unproven, Painkillers
The Detroit News, January 2, 2017 - Off-Label Use: Should Drugs Do Double Duty?
Consumer Reports, December 29, 2016 - Mandatory Participation Killed the Part B Demo
Modern Healthcare, December 16, 2016 - US Toughens Rules for Clinical-Trial Transparency
Nature, September 16, 2016 - Lack of Regulation Allows Pharmaceutical Companies to Raise Prices of Lifesaving Drugs, Expert Says
Wisconsin Public Radio, September 6, 2016
Welcome
The Center for Drug Safety and Effectiveness seeks to improve the safe and effective use of medications through a fourfold mission – training, research, patient care and public service – towards best medication practices.
Upcoming
'Safety, Value and Innovation' Seminar Series
The seminar series hosts nationally renowned thought leaders from academia, government and the private sector. The series will resume in September 2017.
New Faculty Opening
The Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health (JHSPH) invites applications for a tenure track position as Assistant or Associate Professor in pharmacoepidemiology.
Learn MoreTraining
The Center for Drug Safety and Effectiveness is training the next generation of leaders in pharmacoepidemiology and drug safety. The Center supports a diverse group of trainees, from masters' and doctoral students to clinical residents, fellows and junior faculty.
Learn More